News

The final rules address certain provisions of the July and October 2021 interim final rules that are relevant to the operation of the federal IDR process and revise certain provisions.

"There are issues of reimbursement, equitable access to vaccines and treatment, and distribution that need to be resolved," says Anne McDonald Pritchett, senior vice president of PhRMA.

The legislation would require the U.S. Secretary of Health and Human Services to negotiate directly with drug manufacturers over the price of some high-cost drugs in the Medicare program.

Attorneys argued that the law, which limits how much patients have to pay out-of-network providers in emergencies and other scenarios, violated physicians' Fifth, Seventh and Fourteenth Amendment rights.

For millions of families living with chronic diseases or other debilitating conditions, inflation is proving a punishing scourge that could be harmful to their health.

WTW official: Dobbs decision raises questions with no immediate answers for employers.